For research use only
| Cat No. | ABC-RC006Y |
| Product Type | Reporter Stable Cell Lines |
| Cell Type | Epithelial |
| Species | Mouse |
| Host Cell | KLN205 |
| Source Organ | Lung |
| Disease | Squamous Cell Carcinoma |
| Storage | Liquid Nitrogen |
KLN205/STAT5 Reporter (GFP) Stable Cell Line enables real-time GFP-based monitoring of STAT5 pathway activity for cancer and drug discovery research.
KLN205/STAT5 Reporter (GFP) Stable Cell Line is a fluorescent reporter model derived from murine lung squamous carcinoma KLN205 cells, featuring stable integration of a GFP gene under the control of STAT5-responsive promoter elements. This engineered system allows real-time, single-cell monitoring of STAT5 pathway activation through GFP fluorescence, while maintaining the epithelial morphology and tumorigenic properties of parental KLN205 cells. The GFP reporter provides a sensitive tool for visualizing dynamic STAT5 activity in response to cytokines such as IL-2, IL-7, and GM-CSF, or to pharmacological modulators, facilitating research on JAK-STAT signaling and targeted therapy development. Applications include high-content screening of STAT5 modulators, tumor–microenvironment signaling studies, and functional analysis of immune–tumor interactions. Rigorous quality control ensures all cells are free of mycoplasma, fungi, yeast, and bacteria.
| Species | Mouse |
| Cat.No | ABC-RC006Y |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Lung |
| Disease | Squamous Cell Carcinoma |
| Biosafety Level | 2 |
| Storage | Liquid Nitrogen |
| Product Type | Reporter Stable Cell Lines |
| Host Cell | KLN205 |
| Gene Info | GFP (STAT5-responsive reporter) |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The KLN205/STAT5 Reporter (GFP) Stable Cell Line provides a sensitive biosensor system for real-time monitoring of STAT5 signaling activity via GFP expression. It enables dynamic assessment of JAK-STAT pathway activation in response to cytokines, growth factors, or pharmacological agents, making it a valuable tool for investigating oncogenic signaling networks and therapeutic discovery. The GFP readout supports high-throughput STAT5 inhibitor screening, pathway mechanism studies, and functional exploration of tumor–immune cell interactions in lung squamous carcinoma models.